Elevated lipid peroxides induced angiogenesis in proliferative diabetic retinopathy

Journal of Ocular Biology, Diseases, and Informatics

Volumn 3, Issue 3, 2010, Pages 85-87

  Saxena, Sandeep ^a   Srivastava, Prachi ^b   Khanna, Vinay K ^c  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b AMITY UNIVERSITY   (India)

^c Indian Institute of Toxicological Research   (India)

Author keywords

Anti oxidant therapy; Oxidative stress; Platelets; Proliferative diabetic retinopathy; Thiobarbituric acid reacting substances

Indexed keywords

LIPID PEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANGIOGENESIS; ARTICLE; BIOMICROSCOPY; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; LIPID PEROXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; SLIT LAMP; VISUAL ACUITY;

EID: 80054991803     PISSN: 19368437     EISSN: 19368445     Source Type: Journal    
DOI: 10.1007/s12177-011-9059-5     Document Type: Article

References (22)

1. Casey R, Li WW. Factors controlling ocular angiogenesis. Am J Ophthalmol. 1997;124:521-9. (Pubitemid 27425876)
2. Schultz AS, Grant MB. Neovascular growth factors. Eye. 1991;5:170-80.
3. Stefannsson E. Oxygen and diabetic eye disease. Graefes Arch Clin Exp Ophthalmol. 1990;228:120-3.
4. Srivastava S, Joshi CS, Sethi PPS, Agrawal AK, Srivastava SK, Seth PK. Altered platelet function in non-insulin dependent diabetes mellitus (NIDDM). Thromb Res. 1994;76:451-61. (Pubitemid 24371675)
5. Saxena S, Khanna VK, Kumar D, Srivastava P, Seth PK. Enhanced oxidative stress in Eales' disease. Ann Ophthalmol. 2001;33:40-2.
6. Saxena S, Kumar D, Srivastava P, Khanna VK, Seth PK. Low levels of platelet glutathione in Eales' disease. Med Sci Res. 1999;42:125-6.
7. Guigliano D, Paolisso G, Ceriello A. Oxidative stress and diabetic complications. Diabetes Care. 1996;19:257-67.
8. Wolff SP. The potential role of oxidative stress in diabetes and its complications: novel implications for theory and therapy. In: Crabbe MJC, editor. Diabetic complications: scientific and clinical aspects. London: Churchill Livingston; 1987. p. 167-221.
9. Jennings PE, McLaren M, Scott NA, Saniabadi JF. The relationship of oxidative stress to thrombotic tendency in type I diabetic patients with diabetic retinopathy. Diabet Med. 1992;8:860-5.
10. Boehme DH, Koseki R, Carson S, Stern F, Marks N. Lipid peroxidation in human and rat brain tissue development and regional studies. Brain Res. 1977;136:11-21. (Pubitemid 8198097)
11. Murugeswari P, Shukla D, Rajendran A, Kim R, Namperumalsamy P, Muthukkaruppan V. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and Eales' disease. Retina. 2008;28:817-24.
12. Abdella N, al Awadi F, Salman A, Armstrong D. Thiobarbituric acid test as a measure of lipid peroxidation in Arab patients with NIDDM. Diab Res. 1990;15:173-7.
13. Kesavulu MM, Giri R, Kameswara Rao B, Apparao C. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diab Metab. 2000;26:387-92.
14. Losada M, Alio JL. Malondialdehyde serum concentration in type 1 diabetic with and without retinopathy. Doc Ophthalmol. 1996-1997;93:223-9. (Pubitemid 28126126)
15. Augustin AJ, Breipohl W, Böker T, Lutz J, Spitznas M. Increased lipid peroxide levels and myeloperoxidase activity in the vitreous of patients suffering from proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 1993;231:647-50. (Pubitemid 23342237)
16. Turk HM, Sevinc A, Camci C, Cigli A, Buyukberber S, Savli H, et al. Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Acta Diabetol. 2002;39:117-22.
17. Armstrong D, Ueda T, Ueda T, et al. Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet-derived growth factor. Angiogenesis. 1998;2:93-104. (Pubitemid 128511976)
18. Augustin AJ, Spitznas M, Koch F, Grus F, Böker T. Indicators of oxidative tissue damage and inflammatory activity in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. Ger J Ophthalmol. 1995;4:47-51.
19. Jamieson D, Chance B, Cadenas E, Boveris A. The relationship of free radical production in hyperoxia. Annu Rev Physiol. 1986;48:703-19. (Pubitemid 16047644)
20. Williamson JR, Chang K, Frangos M, et al. Hyperglycemia pseudohypoxia and diabetic complications. Diabetes. 1993;42:801-13.
21. Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autooxidative glycosylation: glucose autoxidation as the cause of protein damage in experimental glycation model of diabetes mellitus and ageing. Biochem J. 1988;258:205-12.
22. Ahmed MU, Thorpe R, Bayness JW. Identification of N-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem. 1986;261:4889-94. (Pubitemid 17204276)